Form 8-K - Current report:
SEC Accession No. 0001493152-24-052097
Filing Date
2024-12-26
Accepted
2024-12-26 16:05:29
Documents
17
Period of Report
2024-12-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 72125
2 ex10-1.htm EX-10.1 84470
3 ex10-2.htm EX-10.2 68679
4 ex10-3.htm EX-10.3 139542
  Complete submission text file 0001493152-24-052097.txt   666710

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE pwup-20241218.xsd EX-101.SCH 4290
6 XBRL DEFINITION FILE pwup-20241218_def.xml EX-101.DEF 30878
7 XBRL LABEL FILE pwup-20241218_lab.xml EX-101.LAB 38244
8 XBRL PRESENTATION FILE pwup-20241218_pre.xml EX-101.PRE 27897
20 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 7595
Mailing Address 1200 BROADWAY, FLOOR 3 NEW YORK NY 10038
Business Address 1200 BROADWAY, FLOOR 3 NEW YORK NY 10038 561-704-8527
PowerUp Acquisition Corp. (Filer) CIK: 0001847345 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41293 | Film No.: 241581068
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)